Genetic Basis of Ventricular Arrhythmias

Cardiology Clinics

Volumn 26, Issue 3, 2008, Pages 335-353

  Boussy, Tim ^a   Paparella, Gaetano ^a   de Asmundis, Carlo ^a   Sarkozy, Andrea ^a   Chierchia, Gian Battista ^a   Brugada, Josep ^b   Brugada, Ramon ^c   Brugada, Pedro ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b UNIVERSITY OF BARCELONA   (Spain)

^c MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALSEQUESTRIN; RYANODINE RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BARTH SYNDROME; BRUGADA SYNDROME; CALCIUM CHANNELOPATHY; CARDIAC CHANNELOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHANNEL GATING; CHANNELOPATHY; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; DISEASE ACTIVITY; DISEASE TRANSMISSION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEART CONDUCTION; HEART DEATH; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE POTENTIAL; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ION CURRENT; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; MONOGENIC DISORDER; PATHOPHYSIOLOGY; PEDIGREE ANALYSIS; POTASSIUM CHANNELOPATHY; PRIORITY JOURNAL; PROGRESSIVE CARDIAC CONDUCTION DEFECT; REVIEW; RNA SEQUENCE; SHORT QT SYNDROME; SODIUM CHANNELOPATHY; TIMOTHY SYNDROME; TISSUE SPECIFICITY; X CHROMOSOME; X CHROMOSOME LINKED DISORDER;

ARRHYTHMIAS, CARDIAC; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; BRUGADA SYNDROME; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; HUMANS; INHERITANCE PATTERNS; LONG QT SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; POTASSIUM CHANNELS; SODIUM CHANNELS;

EID: 44449088492     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2008.03.005     Document Type: Review

References (93)

1. Birney E., Stamatoyannopoulos J.A., Dutta A., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 7146 (2007) 799-816
2. Towbin J.A., and Bowles N.E. Human molecular genetics and the heart. In: Zipes D.P., and Jalife J. (Eds). Cardiac electrophysiology, from cell to bedside. 4th edition (2004), Saunders 444-461
3. Noda M., Shimizu S., Tanabe T., et al. Primary structure of electrophorus electricus sodium channel deduced form cDNA sequence. Nature 312 (1984) 121-127
4. Marban E.T., Yamagisji T., and Tomaselli G.F. Structure and function of voltage gated sodium channels. J Physiol 508 3 (1998) 647-657
5. Balser J.R. The cardiac sodium channel: gating function and molecular pharmacology. J Mol Cell Cardiol 33 4 (2001) 599-613
6. Grant A.O., Carboni M.P., Neplioueva V., et al. Long QT-syndrome, Brugada syndrome and conduction disease are linked to a single sodium channel mutation. J Clin Invest 110 (2002) 1201-1209
7. Brugada P., and Brugada J. Right bundle branch block, persistent ST-segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20 (1992) 1391-1396
8. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: report of the second consensus conference. Circulation 111 (2005) 659-670
9. Chen Q., Kirsch G.E., Zhang D., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 (1998) 293-296
10. Weiss R., Barmada M.M., Nguyen T., et al. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation 105 (2002) 707-713
11. London B., Sanyal S., Michalec M., et al. A mutation in the glycerol-3-phosphate dehydrogenase 1-like gen (GPD1L) causes Brugada syndrome. Circulation 116 20 (2007) 2260-2268
12. Bezzina C.R., Shimizu W., Yang P., et al. Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 113 (2006) 338-344
13. Poelzing S., Forleo C., Samodell M., et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation 114 (2006) 368-376
14. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 12 (2001) 268-272
15. Meregallli P.G., Wilde A.A., and Tan H.L. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?. Cardiovasc Res 67 (2005) 367-378
16. Lenègre J., and Moreau P.H. Le bloc auriculo-ventriculaire chronique: etude anatomique, clinique et histologique. Arch Mal Coeur Vaiss 56 (1963) 867-888
17. Lev M. Anatomic basis of atrioventricular block. Am J Cardiol 37 (1964) 742-748
18. Combrink J.M., Davis W.H., Snyman H.W., et al. Familial bundle branch block. Am Heart J 64 (1962) 397-400
19. Steenkamp W.F. Familial trifascicular block. Am Heart J 84 (1972) 758-760
20. Brink P.A., Ferreira A., Moolman J.C., et al. Gene for progressive familial heart block type I maps to chromosome 19q13. Circulation 91 (1995) 1633-1640
21. Scott J.J., Alshinawi C., Kyndt F., et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 23 (1999) 20-21
22. Probst V., Kyndt F., Potet F., et al. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease. J Am Coll Cardiol 41 4 (2003) 643-652
23. Rivolta I., Abriel H., Tateyama M., et al. Inherited Brugada and LQT3-syndrome mutations of a single residue of the cardiac sodium channel confer distinct channel and clinical phenotypes. J Biol Chem 276 (2001) 30623-30630
24. Deal K.K., England S.K., and Tamkun M.M. Molecular physiology of cardiac potassium channels. Physiol Rev 76 (1996) 49-67
25. Pongs O., Leicher T., Berger M., et al. Functional and molecular aspects of voltage-gated K-channel B subunits. Ann N Y Acad Sci 868 (1999) 344-355
26. Yellen G. The voltage-gated potassium channels and their relatives. Nature 419 (2002) 36-42
27. Modell S.M., and Lehmann M.H. The long QT syndrome family of cardiac ion channelopathies: a HuGE review. Genet Med 8 3 (2006) 143-155
28. Yoshiyasu A., Kazuo U., Fabiana S., et al. A novel mutation in KCN1 associated with a potent dominant negative effect as the basis for the LQT1 form of the long QT syndrome. J Cardiovasc Electrophysiol 18 (2007) 972-977
29. Craig T.J., Qiuming G., Zhou Z., et al. Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2. J Cardiovasc Electrophysiol 11 (2000) 1413-1418
30. Sanguinetti M.C., and Keating M.T. Role of delayed rectifier potassium channels in cardiac repolarization and arrhythmias. News Physiol Sci 12 (1997) 152-157
31. Sanguinetti M.C., Jiang C., Curran M.E., et al. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the Ikr potassium channel. Cell 81 (1995) 299-307
32. Laura B., Zhijun S., Dennis A.T., et al. Cellular dysfunction of LQT5-minK mutants: abnormalities of Iks, Ikr and trafficking in long QT syndrome. Hum Mol Genet 8 (1999) 1499-1507
33. Curran M.E., Splawski I., Timothy K.W., et al. A molecular basis for cardiac arrhythmias: HERG mutations cause long QT syndrome. Cell 80 (1995) 795-803
34. Tsuboi M., and Antzelevitch C. Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7). Heart Rhythm 3 (2006) 328-335
35. Gussak I., Brugada P., Brugada J., et al. Idiopathic short QT-interval: a new clinical syndrome?. Cardiology 94 (2000) 99-102
36. Gaita F., Cuistetto C., Bianchi F., et al. Short QT-syndrome: a familial cause of sudden death. Circulation 108 (2003) 965-970
37. Brugada R., Hong K., Cordeiro J.M., et al. Short QT-syndrome. CMAJ 173 II (2005) 1349-1354
38. Brugada R., Hong K., Dumaine R., et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109 (2004) 30-35
39. Hong K., Bjerregaard P., Gussak I., et al. Short QT-syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol 16 (2005) 394-396
40. Hong K., Piper D.R., Diaz-Valdecantos A., et al. De novo KCNQ1-mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res 68 3 (2005) 1310-1325
41. Priori S.G., Pandit S.V., Rivolta I., et al. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96 (2005) 800-807
42. Ertel E.A., Campbell K.P., Harpold M.M., et al. Nomenclature of voltage-gated calcium channels. Neuron 25 (2000) 533-535
43. Splaswski I., Timothy K.W., Sharpe L.M., et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119 (2004) 19-31
44. Mckeown L., Robinson P., and Jones T. Molecular basis of inherited calcium channelopathies: role of mutations in pore forming units. Acta Pharmacol Sin 27 7 (2006) 799-812
45. Lehnart S.E., Ackerman M.J., Benson D.W., et al. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel dysfunction. Circulation 116 (2007) 2325-2345
46. Pitt G.S., Dun W., and Boyden P. Remodeled cardiac calcium channels. J Mol Cell Cardiol 41 (2006) 373-388
47. Mohamed U., Napolitano C., and Priori S.G. Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. J Cardiovasc Electrophysiol 18 (2007) 791-797
48. Liu N., Colombi B., Raytcheva-Buono E., et al. Catecholaminergic polymorphic ventricular tachycardia. Herz 32 (2007) 212-217
49. Wehrens X.H., Lenhart S.E., Huang F., et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise induced sudden cardiac death. Cell 113 (2003) 829-840
50. Maron B.J., Gardin J.M., Flack J.M., et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92 (1995) 785-789
51. Zou Y., Song L., Wang Z., et al. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based analysis of 8080 adults. Am J Med 116 (2004) 14-18
52. Van Driest S.L., Ellsworth E.G., Ommen S.R., et al. Prevalence and spectrum of thin filament mutations in outpatient referral population with hypertrophic cardiomyopathy. Circulation 108 (2003) 445-451
53. Richard P., Charron P., Carrier L., et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations and implications for a molecular diagnosis strategy. Circulation 107 (2003) 2227-2232
54. Arad M., Maron B.J., Gorham J.M., et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352 (2005) 362-372
55. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 20 (1958) 1-8
56. Maron B.J. Sudden death in young athletes. N Engl J Med 349 (2003) 1064-1075
57. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
58. Hughes S.J. The pathology of hypertrophic cardiomyopathy. Histopathology 44 (2004) 412-427
59. Towbin J.A., and Bowles N.E. The failing heart. Nature 415 (2002) 227-233
60. Seidman J.G., and Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 (2001) 557-567
61. Charron P., Heron D., Gargiulo M., et al. Genetic testing and genetic counseling in hypertrophic cardiomyopathy: the French experience. J Med Genet 39 (2002) 741-746
62. Geisterfer-Lowrance A.A., Kass S., Tanigawa G., et al. A molecular basis for familial hypertrophic cardiomyopathy: a β-myosin heavy chain gene missense mutation. Cell 62 5 (1990) 999-1006
63. Jaenicke T., Diederich K.W., Haas W., et al. The complete sequence of the human β myosin heavy chain gene and a comparative analysis of its product. Genomics 8 (1990) 194-197
64. Liew C.C., Sole M.J., Yamauchi-Takihara K., et al. Complete sequence and organization of the human cardiac β myosin heavy chain gene. Nucleic Acids Res 18 (1990) 3647-3652
65. Watkins H., McKenna W.J., Thierfelder L., et al. Mutations in the genes for cardiac troponin T and α tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332 (1995) 1058-1063
66. Nimura H., Bachinski L.L., Sangwatanaroj S., et al. Mutations in the gene for cardiac myosin binding protein C and late onset familial hypertrophic cardiomyopathy. N Engl J Med 338 (1998) 1248-1253
67. Rottbauer W., Gautel M., Zehelein J., et al. Novel splice donor site mutation in the cardiac myosin binding protein C gene in familial hypertrophic cardiomyopathy: characterization of cardiac transcript and protein. J Clin Invest 100 (1997) 475-478
68. Moolman J.C., and Corfield V.A. Sudden death due to troponin T mutations. J Am Coll Cardiol 29 (1997) 549-554
69. Poetter K., Jiang H., Hassanzadeh S., et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 13 (1996) 63-66
70. Olson T.M., Michels V.V., Thibodeau S.N., et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280 (1998) 750-752
71. Blair E., Redwood C., Ashrafian H., et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 10 (2001) 1215-1220
72. Basso C., Thiene G., Corrado D., et al. Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy or myocarditis?. Circulation 94 (1996) 983-991
73. Corrado D., Fontine G., Marcus F.I., et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for international registry. Study group on arrhythmogenic right ventricular dysplasia/cardiomyopathy of the working groups of myocardial and pericardial disease and arrhythmias of the European Society of Cardiology and of the Scientific Council of Cardiomyopathies of the World Heart Federation. Circulation 101 (2000) E101-E106
74. Rampazzo A., Beggagna G., Nava A., et al. Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes. Eur J Hum Genet 11 (2003) 69-76
75. Tiso N., Stephan D.A., Nava A., et al. Identification of mutations in the cardiac ryanodine receptor gene in family affected by arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10 (2001) 189-194
76. Marx S.O., Reiken S., Hisamatsu Y., et al. PKA phosphorylation dissociates FKBP12,6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
77. Moren A., Ichijo H., and Miyazono K. Molecular cloning and characterization of the human and porcine transforming growth factor beta-type III receptors. Biochem Biophys Res Commun 189 (1992) 356-362
78. Severini G.M., Krajinovic M., Pinamonti B., et al. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 31 (1996) 193-200
79. Rampazzo A., Nava A., Miorin M., et al. ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. Genomics 45 (1997) 259-263
80. Ahmad F., Li D., Karibe A., et al. Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation 98 (1998) 2791-2795
81. Asano Y., Takashima S., Asakura M., et al. Lamr1 functional retroposon causes right ventricular dysplasia in mice. Nat Genet 36 (2004) 123-130
82. Li D., Ahmad F., Gardner M.J., et al. The locus of a new gene responsible for arrhythmogenic right ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14. Am J Hum Genet 66 (2000) 148-156
83. Ferreiro A., Ceuterick-de Groote C., Marks J.J., et al. Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol 55 5 (2004) 676-686
84. Seicen D., and Engel A.G. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 57 (2005) 269-276
85. Rampazzo A., Nava A., Malacrida S., et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular dysplasia. Am J Hum Genet 71 (2002) 1200-1206
86. Grossmann K.S., Grund C., Huelsken J., et al. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol 167 (2004) 149-160
87. Gerull B., Heuser A., Wichter T., et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 36 (2004) 1162-1164
88. Arnemann J., Spurr N.K., Magee A.I., et al. The human gene (DSG2) coding for HDGC, a second member of the desmoglein subfamily of the desmosomal cadherins, is like DSG1coding for desmoglein DGI, assigned to chromosome 18. Genomics 13 (1992) 484-486
89. Awad M.M., Dalal D., Cho E., et al. DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Hum Genet 79 (2006) 136-142
90. Syrris P., Ward D., Evans A., et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 79 (2006) 978-984
91. Sinagra G., Di Lenarda A., Brodsky G.L., et al. Current perspectives: new insights into the molecular basis of familial dilated cardiomyopathy. Ital Heart J 2 (2001) 280-286
92. Kass S., MacRae C., Graber H.L., et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet 7 (1994) 546-551
93. Bowles N.E., Bowles K.R., and Towbin J.A. The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 25 (2000) 168-175